188 related articles for article (PubMed ID: 29337044)
1. Lysophosphatidic acid regulates the motility of MCF10CA1a breast cancer cell sheets via two opposing signaling pathways.
Stuelten CH; Lee RM; Losert W; Parent CA
Cell Signal; 2018 May; 45():1-11. PubMed ID: 29337044
[TBL] [Abstract][Full Text] [Related]
2. Role of lysophosphatidic acid and rho in glioma cell motility.
Manning TJ; Parker JC; Sontheimer H
Cell Motil Cytoskeleton; 2000 Mar; 45(3):185-99. PubMed ID: 10706774
[TBL] [Abstract][Full Text] [Related]
3. Real-time motion analysis reveals cell directionality as an indicator of breast cancer progression.
Weiger MC; Vedham V; Stuelten CH; Shou K; Herrera M; Sato M; Losert W; Parent CA
PLoS One; 2013; 8(3):e58859. PubMed ID: 23527039
[TBL] [Abstract][Full Text] [Related]
4. Lysophosphatidic acid induces focal adhesion assembly through Rho/Rho-associated kinase pathway in human ovarian cancer cells.
Sawada K; Morishige Ki; Tahara M; Ikebuchi Y; Kawagishi R; Tasaka K; Murata Y
Gynecol Oncol; 2002 Dec; 87(3):252-9. PubMed ID: 12468322
[TBL] [Abstract][Full Text] [Related]
5. LPA Induces Colon Cancer Cell Proliferation through a Cooperation between the ROCK and STAT-3 Pathways.
Leve F; Peres-Moreira RJ; Binato R; Abdelhay E; Morgado-Díaz JA
PLoS One; 2015; 10(9):e0139094. PubMed ID: 26418031
[TBL] [Abstract][Full Text] [Related]
6. LPA, HGF, and EGF utilize distinct combinations of signaling pathways to promote migration and invasion of MDA-MB-231 breast carcinoma cells.
Harrison SM; Knifley T; Chen M; O'Connor KL
BMC Cancer; 2013 Oct; 13():501. PubMed ID: 24160245
[TBL] [Abstract][Full Text] [Related]
7. Autotaxin produced by stromal cells promotes LFA-1-independent and Rho-dependent interstitial T cell motility in the lymph node paracortex.
Katakai T; Kondo N; Ueda Y; Kinashi T
J Immunol; 2014 Jul; 193(2):617-26. PubMed ID: 24935929
[TBL] [Abstract][Full Text] [Related]
8. Lysophosphatidic acid induces a migratory phenotype through a crosstalk between RhoA-Rock and Src-FAK signalling in colon cancer cells.
Leve F; Marcondes TG; Bastos LG; Rabello SV; Tanaka MN; Morgado-Díaz JA
Eur J Pharmacol; 2011 Dec; 671(1-3):7-17. PubMed ID: 21968138
[TBL] [Abstract][Full Text] [Related]
9. The G12/13-RhoA signaling pathway contributes to efficient lysophosphatidic acid-stimulated cell migration.
Bian D; Mahanivong C; Yu J; Frisch SM; Pan ZK; Ye RD; Huang S
Oncogene; 2006 Apr; 25(15):2234-44. PubMed ID: 16301993
[TBL] [Abstract][Full Text] [Related]
10. β-Arrestin2 regulates lysophosphatidic acid-induced human breast tumor cell migration and invasion via Rap1 and IQGAP1.
Alemayehu M; Dragan M; Pape C; Siddiqui I; Sacks DB; Di Guglielmo GM; Babwah AV; Bhattacharya M
PLoS One; 2013; 8(2):e56174. PubMed ID: 23405264
[TBL] [Abstract][Full Text] [Related]
11. LPA(1) -induced migration requires nonmuscle myosin II light chain phosphorylation in breast cancer cells.
Kim JH; Adelstein RS
J Cell Physiol; 2011 Nov; 226(11):2881-93. PubMed ID: 21302283
[TBL] [Abstract][Full Text] [Related]
12. Curcumin inhibits LPA-induced invasion by attenuating RhoA/ROCK/MMPs pathway in MCF7 breast cancer cells.
Sun K; Duan X; Cai H; Liu X; Yang Y; Li M; Zhang X; Wang J
Clin Exp Med; 2016 Feb; 16(1):37-47. PubMed ID: 25596714
[TBL] [Abstract][Full Text] [Related]
13. Unmasking of LPA1 receptor-mediated migration response to lysophosphatidic acid by interleukin-1β-induced attenuation of Rho signaling pathways in rat astrocytes.
Sato K; Horiuchi Y; Jin Y; Malchinkhuu E; Komachi M; Kondo T; Okajima F
J Neurochem; 2011 Apr; 117(1):164-74. PubMed ID: 21244430
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of migration and invasion of hepatoma cells via a Rho GTPase signaling pathway.
Wang DS; Dou KF; Li KZ; Song ZS
World J Gastroenterol; 2004 Jan; 10(2):299-302. PubMed ID: 14716844
[TBL] [Abstract][Full Text] [Related]
15. The Rho/ROCK pathway for lysophosphatidic acid-induced proteolytic enzyme expression and ovarian cancer cell invasion.
Jeong KJ; Park SY; Cho KH; Sohn JS; Lee J; Kim YK; Kang J; Park CG; Han JW; Lee HY
Oncogene; 2012 Sep; 31(39):4279-89. PubMed ID: 22249252
[TBL] [Abstract][Full Text] [Related]
16. Lysophosphatidic acid induces MDA-MB-231 breast cancer cells migration through activation of PI3K/PAK1/ERK signaling.
Du J; Sun C; Hu Z; Yang Y; Zhu Y; Zheng D; Gu L; Lu X
PLoS One; 2010 Dec; 5(12):e15940. PubMed ID: 21209852
[TBL] [Abstract][Full Text] [Related]
17. Lysophosphatidic acid stimulates cell growth by different mechanisms in SKOV-3 and Caov-3 ovarian cancer cells: distinct roles for Gi- and Rho-dependent pathways.
Hurst JH; Hooks SB
Pharmacology; 2009; 83(6):333-47. PubMed ID: 19420982
[TBL] [Abstract][Full Text] [Related]
18. Small GTP-binding protein, Rho, both increased and decreased cellular motility, activation of matrix metalloproteinase 2 and invasion of human osteosarcoma cells.
Matsumoto Y; Tanaka K; Harimaya K; Nakatani F; Matsuda S; Iwamoto Y
Jpn J Cancer Res; 2001 Apr; 92(4):429-38. PubMed ID: 11346466
[TBL] [Abstract][Full Text] [Related]
19. Activation of p21-activated kinase 1 is required for lysophosphatidic acid-induced focal adhesion kinase phosphorylation and cell motility in human melanoma A2058 cells.
Jung ID; Lee J; Lee KB; Park CG; Kim YK; Seo DW; Park D; Lee HW; Han JW; Lee HY
Eur J Biochem; 2004 Apr; 271(8):1557-65. PubMed ID: 15066181
[TBL] [Abstract][Full Text] [Related]
20. The lysophosphatidic acid-regulated signal transduction network in ovarian cancer cells and its role in actomyosin dynamics, cell migration and entosis.
Ojasalu K; Lieber S; Sokol AM; Nist A; Stiewe T; Bullwinkel I; Finkernagel F; Reinartz S; Müller-Brüsselbach S; Grosse R; Graumann J; Müller R
Theranostics; 2023; 13(6):1921-1948. PubMed ID: 37064875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
